EAM
GPCR icon

EFG Asset Management’s Structure Therapeutics GPCR Stock Holding History

EFG Asset Management’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-26,153
Closed -$1.12M – 200
2024
Q1 		$1.12M Buy
26,153
+8,763
+50% +$370K 0.19% 178
2023
Q4 		$705K Buy
+17,390
New +$997K 0.13% 181

Other funds holding GPCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

EFG Asset Management's GPCR Position: Q2 2024 in Review

EFG Asset Management sold out of Structure Therapeutics (GPCR) in Q2 2024, closing a stake of 26,153 shares — an estimated $1.12M sold.

EFG Asset Management first reported a position in GPCR in Q4 2023 and held it in 2 quarters. The position peaked at $1.12M in Q1 2024. 166 funds tracked by Wall St. Rank hold GPCR as of Q2 2024.

  • EFG Asset Management reported no remaining Structure Therapeutics position as of Q2 2024 after selling out during the quarter.
  • EFG Asset Management sold 26,153 Structure Therapeutics shares in Q2 2024, an estimated $1.12M.
  • EFG Asset Management first reported a position in Structure Therapeutics in Q4 2023 and held it in 2 quarters.
  • EFG Asset Management's Structure Therapeutics position peaked at $1.12M in Q1 2024.
  • 166 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2024.

Based on EFG Asset Management's 13F filing for Q2 2024, filed 25 Jul 2024.